Nanobiosym
Nanobiosym is dedicated to creating a new science that integrates physics, biomedicine, and nanotechnology. The company focuses on incubating transformational technologies with the potential for game-changing impact in global health, energy, and the environment. Led by Dr. Anita Goel, Nanobiosym develops portable diagnostic platforms like Gene-RADAR® to revolutionize healthcare and address pressing global challenges. The company's mission emphasizes fearlessness, focus, transparency, steadfastness, self-discipline, truthfulness, and renunciation to create sustainable impact worldwide.
Industries
Nr. of Employees
small (1-50)
Nanobiosym
Cambridge, Massachusetts, United States, North America
Patents
Single-molecule platform for drug discovery: methods and apparatuses for drug discovery, including discovery of anticancer and antiviral agents
US-11807892-B2
View DetailsSystems and methods for mobile device analysis of nucleic acids and proteins
US-10933417-B2
View DetailsSingle-molecule platform for drug discovery: methods and apparatuses for drug discovery, including discovery of anticancer and antiviral agents
US-9862984-B2
View DetailsNano biofuel production processes: using nantechnology to enhance production fo biofuels
US-9828580-B2
View Details
Single-molecule platform for drug discovery: methods and apparatuses for drug discovery, including discovery of anticancer and antiviral agents
US-11807892-B2
View DetailsSystems and methods for mobile device analysis of nucleic acids and proteins
US-10933417-B2
View DetailsSingle-molecule platform for drug discovery: methods and apparatuses for drug discovery, including discovery of anticancer and antiviral agents
US-9862984-B2
View DetailsNano biofuel production processes: using nantechnology to enhance production fo biofuels
US-9828580-B2
View DetailsProducts
Portable genetic detection device
A portable, consumer- or clinic-facing diagnostic device designed to rapidly detect genetic fingerprints (nucleic acid signatures) from biological samples for infectious diseases and other targets, with short turnaround times suitable for point-of-care use.
Enhanced PCR / nano‑PCR platform
A molecular amplification and detection platform applying PCR or enhanced 'nano‑PCR' methods intended to reduce assay time and increase sensitivity for diagnostic applications.
Portable genetic detection device
A portable, consumer- or clinic-facing diagnostic device designed to rapidly detect genetic fingerprints (nucleic acid signatures) from biological samples for infectious diseases and other targets, with short turnaround times suitable for point-of-care use.
Enhanced PCR / nano‑PCR platform
A molecular amplification and detection platform applying PCR or enhanced 'nano‑PCR' methods intended to reduce assay time and increase sensitivity for diagnostic applications.
Services
Deployment and operation of mobile and point-of-care diagnostic testing services for near-patient use.
Contract research engagements for assay development, device R&D, and translational research.
Advisory services including technical due diligence and strategy for deep-technology projects in diagnostics and nanobiotech.
Provision of PCR-based diagnostic assay development and testing services.
Support for clinical trial enrollment and for the clinical validation of diagnostic tests.
Deployment and operation of mobile and point-of-care diagnostic testing services for near-patient use.
Contract research engagements for assay development, device R&D, and translational research.
Advisory services including technical due diligence and strategy for deep-technology projects in diagnostics and nanobiotech.
Provision of PCR-based diagnostic assay development and testing services.
Support for clinical trial enrollment and for the clinical validation of diagnostic tests.
Expertise Areas
- Point-of-care molecular diagnostics
- Nanobiophysics and molecular nanomachines
- PCR and assay development
- Clinical validation and trial support
Key Technologies
- Portable nucleic acid detection
- PCR / enhanced nano‑PCR
- Point-of-care diagnostics
- Molecular-scale device engineering
News & Updates
Nanobiosym received the Gold Medal for its innovative efforts to decentralize, personalize, and mobilize healthcare globally for 8 billion citizens.
Dr. Anita Goel and other experts propose new solutions to end the pandemic.
Nanobiosym was featured in The Atlantic, highlighting its role in innovative healthcare solutions.
Dr. Anita Goel explains how GeneRADAR works and its implications for future healthcare, showcased at the Smithsonian Design Museum.
Nanobiosym Diagnostics was selected as one of the top ten companies bringing solutions to the COVID crisis.
Discusses the importance of mobile testing in safely reopening economies during COVID-19.
Nanobiosym received the Gold Medal for its innovative efforts to decentralize, personalize, and mobilize healthcare globally for 8 billion citizens.
Dr. Anita Goel and other experts propose new solutions to end the pandemic.
Nanobiosym was featured in The Atlantic, highlighting its role in innovative healthcare solutions.
Dr. Anita Goel explains how GeneRADAR works and its implications for future healthcare, showcased at the Smithsonian Design Museum.
Nanobiosym Diagnostics was selected as one of the top ten companies bringing solutions to the COVID crisis.
Discusses the importance of mobile testing in safely reopening economies during COVID-19.